IRVING, Texas--(BUSINESS WIRE)--In a health care landscape that is constantly changing, making and
sustaining quality improvements in patient safety and care can be
understands these challenges and its experts in safety and quality will
be presenting improvement strategies at the IHI
National Forum being held Dec. 9-12 in Orlando.
In addition to being a sponsor for the event, patient safety and quality
IRVING, Texas--(BUSINESS WIRE)--In June 2017, Vizient
began collaborating with the independent software company MedShorts
to develop a first-to-market platform that allows pharmaceutical
manufacturers to channel their surplus inventory directly to hospital
pharmacies. Since that time, over 300,000 units of medication have been
successfully matched and connected to hospital pharmacies with immediate
patient needs, at reduced costs, mitigating obsoletemore...
IRVING, Texas--(BUSINESS WIRE)--Employees from Vizient,
Inc. completed 8000 hours of community service hours as part of the
company’s 16th annual Community Day event held on Oct. 16.
The event included 75
sites, in 42 cities in 19 states.
Included in this year’s 75 sites were food banks, city parks and
homeless shelters as well as projects serving children and adults with
special needs. Volunteers also assisted in Florida with ongoingmore...
IRVING, Texas--(BUSINESS WIRE)--Vizient,
Inc. today announced the winners of its supply chain program awards
for participating Children’s
Hospital Association (CHA) members. The awards, which recognize the
outstanding performance in six categories, were presented at CHA’s
Improving Performance Conference, held Oct. 4 in Glendale, Ariz.
“Our supply chain program for our CHA members offer benefits beyond cost
savings and rebates. Theymore...
IRVING, Texas--(BUSINESS WIRE)--With pharmaceuticals comprising up to 40 percent of a hospital’s supply
spend, and drug price projections predicting a 5-percent increase in
2019 alone, hospital pharmacy teams need analytics to help them better
manage spend and identify cost-savings opportunities across their health
system. To address this need, Vizient
announces it has added a pharmacy
module to its Savings Actualyzer platform.
IRVING, Texas--(BUSINESS WIRE)--Suppliers interested in showcasing their innovative technology to
decision makers from hospitals from across the country are encouraged to
submit their application
now to participate in the 2019
Vizient Innovative Technology Exchange. The event, which is part of
Vizient’s Spring Connections Summit, will take place on Thursday, April
4, 2019, at the Aria in Las Vegas. The deadline to apply to participate
IRVING, Texas--(BUSINESS WIRE)--Vizient
announces its support for the approval of UDENYCA™ (pegfilgrastim-cbqv),
the second pegfilgrastim biosimilar approved by the Food and Drug
Administration (FDA) and the first to be authorized by both the U.S. and
the European Commission for patients with cancer receiving
myelosuppressive chemotherapy. UDENYCA is the first drug from Coherus
BioSciences, Inc. (NASDAQ: CHRS) to receive FDA or EC approvalmore...
IRVING, Texas--(BUSINESS WIRE)--Vizient,
Inc. is disappointed that the Centers for Medicare and Medicaid
Services (CMS) opted to finalize site-neutral payment reductions and the
expansion of payment cuts related to the 340B Drug Pricing Program in
the final 2019 Outpatient Prospective Payment System (OPPS) rule. The
continuation of these damaging cuts will impact hospitals’ ability to
maintain and expand access to care in rural and underservedmore...
IRVING, Texas--(BUSINESS WIRE)--Vizient announces its strong support for the Department of Health and
Human Services’ (HHS) proposed
rule to implement a 340B
Drug Pricing Program regulation that would refine calculations
establishing the 340B ceiling price and apply penalties for drug
manufacturers that knowingly overcharge hospitals for drugs purchased
through the program. The proposed rule would move the effective date to
Jan. 1, 2019more...
IRVING, Texas--(BUSINESS WIRE)--Vizient, the largest member-driven health care performance improvement
company in the country and its subsidiary Provista, a leading supply
chain partner for non-acute health care delivery organizations, urge CMS
to reconsider its approach to the Medicare home infusion therapy benefit
to recognize the full array of services needed for home infusion therapy
Yesterday afternoon CMS finalized a verymore...